Welcome to HOPA (Hematology/Oncology Pharmacy Association), a professional organization dedicated to supporting hematology/oncology pharmacy practitioners in optimizing cancer patient care.

Missed a Member Update?
Visit the Resources section and choose Updates from the menu. This will be the new home for all Member Updates. Stay up to date on all the HOPA happenings and vist there often.

Call for 2011 Research Grant Applications
The HOPA Board and Research Committee announce the opening of a request for proposals for the 2011 HOPA Investigator Research Grant. This grant for an amount up to $50,000 will be awarded in early 2011 through a competitive peer-review process. More information and an application can be found here.

Call for Poster Abstracts is Open for the 2011 Annual Conference.  
HOPA will now accept research poster abstracts for consideration for the HOPA 2011 Annual Conference.

Nominations Open! 2011 Membership and Literature Awards
It’s time to nominate a colleague for a HOPA recognition award! HOPA is seeking nominations for their annual awards, which recognize HOPA members who have shown outstanding achievement in their field. The nomination deadline is August 31, 2010. Nominate someone today! You will be asked to sign on to the members only section of the website if you are not already signed on as a member.

REMS FAQ List
The REMS (Risk Evaluation and Mitigation Strategy) program for the ESA (Erythropoiesis-Stimulating Agents) class of drugs was recently announced. The HOPA Legislative Affairs and Professional Affairs committees would like to collect a series of questions to present to the ESA manufacturers regarding the REMS program. We will compile these questions and the corresponding answers into a Frequently Asked Questions list and make them available to the HOPA membership. Please submit your question regarding the REMS program.


Visit HOPA University!
www.HopaU.org
We currently offer 8 CE activities. Several will be expiring in the upcoming months, so visit HOPA U today!

• Update on Cytomegalovirus and the Role of New and Emerging Therapies
• Integrating the Epothilones into Clinical Practice: Focus On Breast Cancer
• Optimizing Patient Adherence: Best Practices for Hematology/Oncology Pharmacists
• Targeted Drug Therapies for the Treatment of Non–Small-Cell Lung Cancer
• Updates in Cancer Supportive Care: Venous Thromboembolism, Tumor Lysis Syndrome, and CINV